Abstract:Purpose of review Human kidney development and the mechanisms of many kidney diseases are incompletely understood partly due to the lack of appropriate models. Kidney organoids derived from human pluripotent stem cells (hPSCs) are a new and rapidly developing in-vitro system covering the window of early nephrogenesis and having the capacity for disease modelling. The application of global analytic tools such as RNA sequencing and proteomics is providing new and unexpected insights into kidney organoids with relevance for development and disease. In this review, we focus on the most significant advances in the field over the last 2 years. Recent findings There have been several protocol modifications for the differentiation of hPSCs into kidney organoids , including the additional step of implantation into mice. These changes have improved the vascularization and maturity of the major cell types in the organoids, increased the production scale, and reduced the cost and labour intensity of culturing organoids. Single-cell RNA sequencing and global proteomics of kidney organoids have provided important insights into the multiple cell populations, origin of cells, and regulatory relationships between genes. There has been an increase in research using patient-derived induced pluripotent stem cells (iPSCs), or combining gene editing with iPSC-derived kidney organoids as a novel disease-modelling platform for improving our understanding of disease mechanisms, drug testing and discovery, and the potential for personalized therapy. Finally, there has been progress in culturing hPSCs-derived kidney cells in microfluidic kidney-on-a-chip devices and this may provide a means of further improving the maturity of kidney organoids . Summary The review summarizes the latest progress on kidney organoids including differentiation protocols, analysis tools, and applications. Despite some limitations, hPSC-derived kidney organoids are authentic and practical models for investigating kidney development and disease and progressing understanding about tissue regeneration, drug screening , and disease modelling.

Kidney micro-organoids in suspension culture as a scalable source of human pluripotent stem cell-derived kidney cells

Protocol for Large-Scale Production of Kidney Organoids from Human Pluripotent Stem Cells

An efficient method to generate kidney organoids at the air-liquid interface

Generating Kidney Organoids in Suspension from Induced Pluripotent Stem Cells.

Kidney organoids as a promising tool in nephrology

[Modern research on connective tissue and its relation to clinical practice].

Magnetic circular dichroism of purified forms of rabbit liver cytochromes P-450 and P-420.

The myriad possibility of kidney organoids

Single Cell Sequencing and Kidney Organoids Generated from Pluripotent Stem Cells

Generation of Human PSC-Derived Kidney Organoids with Patterned Nephron Segments and a De Novo Vascular Network

Generation of proximal tubule-enhanced kidney organoids from human pluripotent stem cells

Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells

In vitro induction and in vivo engraftment of kidney organoids derived from human pluripotent stem cells

Engineering physiological environments to advance kidney organoid models from human pluripotent stem cells

Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing

Tubuloid culture enables long-term expansion of functional human kidney tubule epithelium from iPSC-derived organoids

Human Bone Marrow‐Derived Mesenchymal Stem Cells Suppress Human Glioma Growth Through Inhibition of Angiogenesis

Generation of kidney organoids from human pluripotent stem cells

Stress in the Police Service

Kidney Disease Modeling with Organoids and Organs-on-Chips

Directed differentiation of ureteric bud and collecting duct organoids from human pluripotent stem cells